Clinical Research Directory
Browse clinical research sites, groups, and studies.
Tumor Rebiopsy During Progression Under Immunotherapy for Patients With Lung Cancer
Sponsor: Assistance Publique - Hôpitaux de Paris
Summary
The objective of the study aims to collect tumor tissue at the moment of progression under Immune checkpoint inhibitors (ICI) in biological resources center in Ambroise Paré hospital, in order to insure later study on molecular mechanism involving the progression of NSCLC and SCLC under ICI. The further analysis of research will be performed in the EA 4340 unity, Biomarkers and Clinical Trials in cancerology and onco-hematology, UVSQ, University of Paris-Saclay.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
50
Start Date
2020-08-18
Completion Date
2027-08
Last Updated
2025-09-03
Healthy Volunteers
No
Conditions
Interventions
Rebiopsy
Biopsy will be carry out with flexible bronchoscopy as usual practice under local anesthesia: under endobronchial ultrasound, punction under CT scan or ultrasonography, percutaneous pleural puncturing.
Locations (1)
Service de Pneumologie et Oncologie thoracique, Hôpital Ambroise Paré, APHP
Boulogne-Billancourt, France